-
Je něco špatně v tomto záznamu ?
Immunoprofiling of monocytes in STAT1 gain-of-function chronic mucocutaneous candidiasis
M. Bloomfield, I. Zentsova, T. Milota, A. Sediva, Z. Parackova
Jazyk angličtina Země Švýcarsko
Typ dokumentu časopisecké články
NLK
Directory of Open Access Journals
od 2010
Free Medical Journals
od 2010
PubMed Central
od 2010
Europe PubMed Central
od 2010
Open Access Digital Library
od 2010-01-01
Open Access Digital Library
od 2010-01-01
ROAD: Directory of Open Access Scholarly Resources
od 2010
- MeSH
- aktivační mutace MeSH
- antifungální látky MeSH
- cytokiny metabolismus MeSH
- kandidóza chronická mukokutánní * genetika MeSH
- lidé MeSH
- monocyty metabolismus MeSH
- toll-like receptor 7 metabolismus MeSH
- transkripční faktor STAT1 genetika metabolismus MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
Patients with STAT1 gain-of-function (GOF) mutations suffer from an inborn error of immunity hallmarked by chronic mucocutaneous candidiasis (CMC). The pathogenesis behind this complex and heterogeneous disease is still incompletely understood. Beyond the well-recognized Th17 failure, linked to the STAT1/STAT3 dysbalance-driven abrogation of antifungal defense, only little is known about the consequences of augmented STAT1 signaling in other cells, including, interestingly, the innate immune cells. STAT1-mediated signaling was previously shown to be increased in STAT1 GOF CD14+ monocytes. Therefore, we hypothesized that monocytes might represent important co-orchestrators of antifungal defense failure, as well as various immunodysregulatory phenomena seen in patients with STAT1 GOF CMC, including autoimmunity. In this article, we demonstrate that human STAT1 GOF monocytes are characterized by proinflammatory phenotypes and a strong inflammatory skew of their secretory cytokine profile. Moreover, they exhibit diminished CD16 expression, and reduction of classical (CD14++C16-) and expansion of intermediate (CD14++16+) subpopulations. Amongst the functional aberrations, a selectively enhanced responsiveness to TLR7/8 stimulation, but not to other TLR ligands, was noted, which might represent a contributing mechanism in the pathogenesis of STAT1 GOF-associated autoimmunity. Importantly, some of these features extend to STAT1 GOF monocyte-derived dendritic cells and to STAT1 GOF peripheral myeloid dendritic cells, suggesting that the alterations observed in monocytes are, in fact, intrinsic due to STAT1 mutation, and not mere bystanders of chronic inflammatory environment. Lastly, we observe that the proinflammatory bias of STAT1 GOF monocytes may be ameliorated with JAK inhibition. Taken together, we show that monocytes likely play an active role in both the microbial susceptibility and autoimmunity in STAT1 GOF CMC.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22033294
- 003
- CZ-PrNML
- 005
- 20230131151400.0
- 007
- ta
- 008
- 230120s2022 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3389/fimmu.2022.983977 $2 doi
- 035 __
- $a (PubMed)36172362
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Bloomfield, Marketa $u Department of Immunology, 2ndFaculty of Medicine Charles University, University Hospital in Motol, Prague, Czechia $u Department of Paediatrics, Thomayer University Hospital, First Faculty of Medicine, Charles University, Prague, Czechia
- 245 10
- $a Immunoprofiling of monocytes in STAT1 gain-of-function chronic mucocutaneous candidiasis / $c M. Bloomfield, I. Zentsova, T. Milota, A. Sediva, Z. Parackova
- 520 9_
- $a Patients with STAT1 gain-of-function (GOF) mutations suffer from an inborn error of immunity hallmarked by chronic mucocutaneous candidiasis (CMC). The pathogenesis behind this complex and heterogeneous disease is still incompletely understood. Beyond the well-recognized Th17 failure, linked to the STAT1/STAT3 dysbalance-driven abrogation of antifungal defense, only little is known about the consequences of augmented STAT1 signaling in other cells, including, interestingly, the innate immune cells. STAT1-mediated signaling was previously shown to be increased in STAT1 GOF CD14+ monocytes. Therefore, we hypothesized that monocytes might represent important co-orchestrators of antifungal defense failure, as well as various immunodysregulatory phenomena seen in patients with STAT1 GOF CMC, including autoimmunity. In this article, we demonstrate that human STAT1 GOF monocytes are characterized by proinflammatory phenotypes and a strong inflammatory skew of their secretory cytokine profile. Moreover, they exhibit diminished CD16 expression, and reduction of classical (CD14++C16-) and expansion of intermediate (CD14++16+) subpopulations. Amongst the functional aberrations, a selectively enhanced responsiveness to TLR7/8 stimulation, but not to other TLR ligands, was noted, which might represent a contributing mechanism in the pathogenesis of STAT1 GOF-associated autoimmunity. Importantly, some of these features extend to STAT1 GOF monocyte-derived dendritic cells and to STAT1 GOF peripheral myeloid dendritic cells, suggesting that the alterations observed in monocytes are, in fact, intrinsic due to STAT1 mutation, and not mere bystanders of chronic inflammatory environment. Lastly, we observe that the proinflammatory bias of STAT1 GOF monocytes may be ameliorated with JAK inhibition. Taken together, we show that monocytes likely play an active role in both the microbial susceptibility and autoimmunity in STAT1 GOF CMC.
- 650 _2
- $a antifungální látky $7 D000935
- 650 12
- $a kandidóza chronická mukokutánní $x genetika $7 D002178
- 650 _2
- $a cytokiny $x metabolismus $7 D016207
- 650 _2
- $a aktivační mutace $7 D000073659
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a monocyty $x metabolismus $7 D009000
- 650 _2
- $a transkripční faktor STAT1 $x genetika $x metabolismus $7 D050794
- 650 _2
- $a toll-like receptor 7 $x metabolismus $7 D051199
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Zentsova, Irena $u Department of Immunology, 2ndFaculty of Medicine Charles University, University Hospital in Motol, Prague, Czechia
- 700 1_
- $a Milota, Tomas $u Department of Immunology, 2ndFaculty of Medicine Charles University, University Hospital in Motol, Prague, Czechia
- 700 1_
- $a Sediva, Anna $u Department of Immunology, 2ndFaculty of Medicine Charles University, University Hospital in Motol, Prague, Czechia
- 700 1_
- $a Parackova, Zuzana $u Department of Immunology, 2ndFaculty of Medicine Charles University, University Hospital in Motol, Prague, Czechia
- 773 0_
- $w MED00181405 $t Frontiers in immunology $x 1664-3224 $g Roč. 13, č. - (2022), s. 983977
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/36172362 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20230120 $b ABA008
- 991 __
- $a 20230131151356 $b ABA008
- 999 __
- $a ok $b bmc $g 1891841 $s 1184629
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2022 $b 13 $c - $d 983977 $e 20220912 $i 1664-3224 $m Frontiers in immunology $n Front Immunol $x MED00181405
- LZP __
- $a Pubmed-20230120